1. Home
  2. NDAQ vs KVUE Comparison

NDAQ vs KVUE Comparison

Compare NDAQ & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDAQ
  • KVUE
  • Stock Information
  • Founded
  • NDAQ 1971
  • KVUE 2022
  • Country
  • NDAQ United States
  • KVUE United States
  • Employees
  • NDAQ N/A
  • KVUE N/A
  • Industry
  • NDAQ Investment Bankers/Brokers/Service
  • KVUE Specialty Chemicals
  • Sector
  • NDAQ Finance
  • KVUE Consumer Discretionary
  • Exchange
  • NDAQ Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • NDAQ 43.7B
  • KVUE 41.1B
  • IPO Year
  • NDAQ 2002
  • KVUE 2023
  • Fundamental
  • Price
  • NDAQ $81.07
  • KVUE $23.33
  • Analyst Decision
  • NDAQ Buy
  • KVUE Buy
  • Analyst Count
  • NDAQ 17
  • KVUE 14
  • Target Price
  • NDAQ $86.88
  • KVUE $23.00
  • AVG Volume (30 Days)
  • NDAQ 2.7M
  • KVUE 15.3M
  • Earning Date
  • NDAQ 01-29-2025
  • KVUE 02-06-2025
  • Dividend Yield
  • NDAQ 1.18%
  • KVUE 3.53%
  • EPS Growth
  • NDAQ N/A
  • KVUE N/A
  • EPS
  • NDAQ 1.93
  • KVUE 0.54
  • Revenue
  • NDAQ $7,400,000,000.00
  • KVUE $15,455,000,000.00
  • Revenue This Year
  • NDAQ N/A
  • KVUE $5.11
  • Revenue Next Year
  • NDAQ $7.83
  • KVUE $3.45
  • P/E Ratio
  • NDAQ $42.18
  • KVUE $43.24
  • Revenue Growth
  • NDAQ 22.03
  • KVUE 0.07
  • 52 Week Low
  • NDAQ $55.52
  • KVUE $17.67
  • 52 Week High
  • NDAQ $84.15
  • KVUE $24.46
  • Technical
  • Relative Strength Index (RSI)
  • NDAQ 50.46
  • KVUE 72.60
  • Support Level
  • NDAQ $80.74
  • KVUE $20.50
  • Resistance Level
  • NDAQ $82.71
  • KVUE $21.10
  • Average True Range (ATR)
  • NDAQ 1.46
  • KVUE 0.61
  • MACD
  • NDAQ -0.12
  • KVUE 0.28
  • Stochastic Oscillator
  • NDAQ 37.14
  • KVUE 96.99

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: